Medicine and Dentistry
Prostaglandin J2
100%
Bone
100%
Breast Cancer
60%
Peroxisome Proliferator Activated Receptor Gamma
40%
Cancer Cell
30%
Osteolysis
30%
Osteoclast Differentiation Factor
30%
Bone Metastasis
30%
Parathyroid Hormone-Related Protein
30%
Cells
30%
Messenger RNA
20%
Serum
20%
Osteoclast
20%
Estrogen Deficiency
20%
Osteoprotegerin
20%
Matrix Metalloproteinase
10%
Intracardiac Injection
10%
Metastatic Carcinoma
10%
Ligand
10%
Osteoclastogenesis
10%
Cathepsin K
10%
Antineoplastic Activity
10%
Estrogen
10%
Antiinflammatory Activity
10%
Osteoplasty
10%
Thioacetazone
10%
Cancer Mortality
10%
Cancer Therapy
10%
Morphometrics
10%
Bone Atrophy
10%
Bone Destruction
10%
Bone Disease
10%
Therapeutic Procedure
10%
Woman
10%
Culture
10%
Lower Jaw
10%
Femur
10%
Bone Cell
10%
Pharmacology, Toxicology and Pharmaceutical Science
Prostaglandin J2
100%
Breast Cancer
60%
Peroxisome Proliferator Activated Receptor Gamma
40%
Osteoclast Differentiation Factor
30%
Bone Metastasis
30%
Parathyroid Hormone Related Protein
30%
Messenger RNA
20%
Osteoprotegerin
20%
Estrogen Deficiency
20%
Ligand
10%
Metastasis
10%
Cancer Mortality
10%
Estrogen
10%
Matrix Metalloproteinase
10%
Institute for Cancer Research Mouse
10%
Cathepsin K
10%
Bone Disease
10%
Bone Destruction
10%
BALB/c Nude Mouse
10%
Thioacetazone
10%
Bone Atrophy
10%
Intracardiac Injection
10%
Biochemistry, Genetics and Molecular Biology
Peroxisome Proliferator-Activated Receptor Gamma
40%
Osteolysis
30%
Parathyroid Hormone-Related Protein
30%
Receptor Activator of Nuclear Factor Kappa-B Ligand
30%
Cancer Cell
20%
Independent Pathway
20%
Osteoprotegerin
20%
Osteoclast
20%
Messenger RNA
20%
Matrix Metalloproteinase
10%
Antineoplastic Activity
10%
Bone Remodeling
10%
Antiinflammatory Activity
10%
BALB/c Nude Mouse
10%
Osteoclastogenesis
10%
Cancer Mortality
10%
Institute for Cancer Research Mouse
10%
Cathepsin K
10%
Parathyroid Hormone Blood Level
10%
Dose
10%